WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 14'9001 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 22'3331 Child (under 5 years) mortality rate: 92

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 17'773  17'620  17'465  17'308  17'151  15'454  13'214  11'192 
Births 245  245  246  246  246  258  305  257 
Surviving infants 244  244  244  244  244  255  301  248 
Pop. less than 5 years 1'221  1'224  1'225  1'226  1'224  1'333  1'466  1'182 
Pop. less than 15 years 3'699  3'715  3'736  3'763  3'797  4'294  3'959  3'701 
Female 15-49 years 4'592  4'594  4'593  4'586  4'571  4'117  3'561  2'913 

Number of reported case

(Click for retrospective incidence data for Chile)
Diphtheria 36  253 
Japanese encephalitis
Measles 1'958  3'844 
Mumps 821  876  950  891  2'352 
Pertussis 1'964  5'762  2'582  794  3'554  59  2'795 
Polio*
Rubella 743 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)** 10  12  22  31 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Chile)
Vaccine year result method % card seen                                                
BCG          98  98  92  91  96  93  94  96 
DTP1          96  92  90  94  93  98 
DTP3          95  91  90  94  92  91  95  93 
DTP4          87 
IPV1         
HepB_BD         
HepB3          90  90  94  92 
Hib3          90  90  94  92  91 
JapEnc         
MCV1          97  90  90  91  93  97  97  94 
MCV2          89  78  74  77  84 
PCV1          96  92  90  83 
PCV3          89  79  82  55 
Pol3          95  90  90  93  92  91  95  93 
Rota1         
Rota_last         
Rubella1          97  90  90  91  93 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Chile)
BCG 98  98  92  91  95  93  94  96 
DTP1 96  92  90  98  93  98  98  97 
DTP3 92  91  90  94  92  91  95  93 
HepB3 92  90  90  94  92 
HepB_BD
Hib3 92  90  90  94  92  91 
MCV1 94  90  90  91  93  97  97  94 
MCV2 88  78  74  77  84 
PCV3 89  79  82  54 
Pol3 92  90  90  93  92  91  95  93 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; Yes
HPV 9 years; Yes
HepA 18 months; No
HepB_Adult health care workers
Influenza 6-23 months; > 65 years; Yes and risk groups
Influenza_Adult >= 65 years; Yes and adults with chronic diseases, health care workers and pregnant women
Influenza_Pediatric 6-23 months; Yes and children with chronic diseases
MMR 1, 6 years; Yes
MenACWY 1 year; Yes
OPV 2, 4, 6, 18 months; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps 65 years; Yes
Tdap 6, 13 years; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  No  No  No 
What years does the MYP cover? number 2010-2020      2'011       
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number   345  346  346    340  346 
Nº districts with DTP3 coverage >=80% number 246  170  238  293  293  299 
% of districts with DTP3 coverage >=80% From 0 to 100%   49  69    86  86 
Nº districts with measles (MCV1) coverage >=95% number 143    84  105  163  163  190 
% of districts with MCV1 coverage >=95% From 0 to 100%     24  30    48  55 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No         
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    No  No  No 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100    100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.